Synergistic Combination Chemotherapy of Camptothecin and Floxuridine through Self-Assembly of Amphiphilic Drug-Drug Conjugate

Bioconjugate Chemistry

Volumn 26, Issue 12, 2015, Pages 2497-2506

  Hu, Minxi ^a   Huang, Ping ^a   Wang, Yao ^a   Su, Yue ^a   Zhou, Linzhu ^a   Zhu, Xinyuan ^a   Yan, Deyue ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL DEATH; CELL PROLIFERATION; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; DRUG DOSAGE; SELF ASSEMBLY;

AMPHIPHILIC DRUGS; ANTI-CANCER AGENTS; BIODISTRIBUTIONS; CAMPTOTHECINS; COMBINATION CHEMOTHERAPY; DRUG-CONJUGATES; NOVEL STRATEGIES; SELF ASSEMBLED NANOPARTICLES; SYNERGISTIC COMBINATIONS; THERAPEUTIC EFFICACY;

NANOPARTICLES;

AMPHOPHILE; CAMPTOTHECIN; CASPASE 3; FLOXURIDINE; NANOPARTICLE; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENTIATION; DRUG RELEASE; HT 29 CELL LINE; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMISTRY; COLON; COLORECTAL NEOPLASMS; DRUG EFFECTS; PATHOLOGY; RECTUM; SYNTHESIS; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; DRUG SYNERGISM; FLOXURIDINE; HUMANS; NANOPARTICLES; RECTUM; TISSUE DISTRIBUTION;

EID: 84950142492     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.5b00513     Document Type: Article

References (34)

1. Hopkins, A. L. (2008) Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 4, 682-690 10.1038/nchembio.118
2. Devita, V. T., Young, R. C., and Canellos, G. P. (1975) Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer Cancer 35, 98-110 10.1002/1097-0142(197501)35:1<98::AID-CNCR2820350115>3.0.CO;2-B
3. White, N. J. and Olliaro, P. L. (1996) Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria Parasitol. Today 12, 399-401 10.1016/0169-4758(96)10055-7
4. Drewinko, B., Loo, T., Brown, B., Gottlieb, J., and Freireich, E. (1976) Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells Cancer Biochem. Biophys. 1, 187-195
5. Kim, Y. H., Shin, S. W., Kim, B. S., Kim, J. H., Kim, J. G., Mok, Y. J., Kim, C. S., Rhyu, H. S., Hyun, J. H., and Kim, J. S. (1999) Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma Cancer 85, 295-301 10.1002/(SICI)1097-0142(19990115)85:2<295::AID-CNCR5>3.3.CO;2-8
6. Hu, C.-M. J. and Zhang, L. (2012) Nanoparticle-based combination therapy toward overcoming drug resistance in cancer Biochem. Pharmacol. 83, 1104-1111 10.1016/j.bcp.2012.01.008
7. Chiu, G. N., Wong, M.-Y., Ling, L.-U., Shaikh, I. M., Tan, K.-B., Chaudhury, A., and Tan, B.-J. (2009) Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: implications on pharmacokinetics and drug toxicities Curr. Drug Metab. 10, 861-874 10.2174/138920009790274531
8. Liu, Y., Fang, J., Kim, Y.-J., Wong, M. K., and Wang, P. (2014) Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity Mol. Pharmaceutics 11, 1651-1661 10.1021/mp5000373
9. Wang, D. L., Tu, C. L., Su, Y., Zhang, C., Greiser, U., Zhu, X. Y., Yan, D. Y., and Wang, W. X. (2015) Supramolecularly engineered phospholipids constructed by nucleobase molecular recognition: upgraded generation of phospholipids for drug delivery Chem. Sci. 6, 3775-3787 10.1039/C5SC01188D
10. Joung, Y. K., Jang, J. Y., Choi, J. H., Han, D. K., and Park, K. D. (2013) Heparin-conjugated pluronic nanogels as multi-drug nanocarriers for combination chemotherapy Mol. Pharmaceutics 10, 685-693 10.1021/mp300480v
11. Wang, W., Despanie, J., Shi, P., Edman, M. C., Lin, Y.-A., Cui, H., Heur, M., Fini, M. E., Hamm-Alvarez, S. F., and MacKay, J. A. (2014) Lacritin-mediated regeneration of the corneal epithelia by protein polymer nanoparticles J. Mater. Chem. B 2, 8131-8141 10.1039/C4TB00979G
12. Han, K., Chen, S., Chen, W.-H., Lei, Q., Liu, Y., Zhuo, R.-X., and Zhang, X.-Z. (2013) Synergistic gene and drug tumor therapy using a chimeric peptide Biomaterials 34, 4680-4689 10.1016/j.biomaterials.2013.03.010
13. Cheetham, A. G., Ou, Y.-C., Zhang, P., and Cui, H. (2014) Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles Chem. Commun. 50, 6039-6042 10.1039/c3cc49453e
14. Shin, H.-C., Alani, A. W., Cho, H., Bae, Y., Kolesar, J. M., and Kwon, G. S. (2011) A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs Mol. Pharmaceutics 8, 1257-1265 10.1021/mp2000549
15. Xiao, H., Song, H., Yang, Q., Cai, H., Qi, R., Yan, L., Liu, S., Zheng, Y., Huang, Y., and Liu, T. (2012) A prodrug strategy to deliver cisplatin (IV) and paclitaxel in nanomicelles to improve efficacy and tolerance Biomaterials 33, 6507-6519 10.1016/j.biomaterials.2012.05.049
16. Li, Z.-Y., Liu, Y., Wang, X.-Q., Liu, L.-H., Hu, J.-J., Luo, G.-F., Chen, W.-H., Rong, L., and Zhang, X.-Z. (2013) One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma ACS Appl. Mater. Interfaces 5, 7995-8001 10.1021/am402082d
17. Lin, Y.-A., Cheetham, A. G., Zhang, P., Ou, Y.-C., Li, Y., Liu, G., Hermida-Merino, D., Hamley, I. W., and Cui, H. (2014) Multiwalled nanotubes formed by catanionic mixtures of drug amphiphiles ACS Nano 8, 12690-12700 10.1021/nn505688b
18. Cheetham, A. G., Zhang, P., Lin, Y.-a., Lock, L. L., and Cui, H. (2013) Supramolecular nanostructures formed by anticancer drug assembly J. Am. Chem. Soc. 135, 2907-2910 10.1021/ja3115983
19. Benson, S. P. and Pleiss, J. r. (2014) Molecular dynamics simulations of self-emulsifying drug-delivery systems (SEDDS): influence of excipients on droplet nanostructure and drug localization Langmuir 30, 8471-8480 10.1021/la501143z
20. Huang, P., Wang, D. L., Su, Y., Huang, W., Zhou, Y. F., Cui, D. X., Zhu, X. Y., and Yan, D. Y. (2014) Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy J. Am. Chem. Soc. 136, 11748-11756 10.1021/ja505212y
21. Wall, M. E., Wani, M., Cook, C., Palmer, K. H., McPhail, A., and Sim, G. (1966) Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata1, 2 J. Am. Chem. Soc. 88, 3888-3890 10.1021/ja00968a057
22. Hsiang, Y.-H., Hertzberg, R., Hecht, S., and Liu, L. (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I J. Biol. Chem. 260, 14873-14878
23. Lu, J., Liu, C., Wang, P., Ghazwani, M., Xu, J., Huang, Y., Ma, X., Zhang, P., and Li, S. (2015) The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin Biomaterials 62, 176-187 10.1016/j.biomaterials.2015.05.046
24. Li, X.-Q., Wen, H.-Y., Dong, H.-Q., Xue, W.-M., Pauletti, G. M., Cai, X.-J., Xia, W.-J., Shi, D., and Li, Y.-Y. (2011) Self-assembling nanomicelles of a novel camptothecin prodrug engineered with a redox-responsive release mechanism Chem. Commun. 47, 8647-8649 10.1039/c1cc12495a
25. Nakagawa, H., Maeda, N., Tsuzuki, T., Suzuki, T., Hirayama, A., Miyahara, E., and Wada, K. (2001) Intracavitary chemotherapy with 5-fluoro-2′-deoxyuridine (FUDRrd) in malignant brain tumors Jpn. J. Clin. Oncol. 31, 251-258 10.1093/jjco/hye055
26. Landowski, C. P., Song, X., Lorenzi, P. L., Hilfinger, J. M., and Amidon, G. L. (2005) Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism Pharm. Res. 22, 1510-1518 10.1007/s11095-005-6156-9
27. Kemeny, N., Jarnagin, W., Gonen, M., Stockman, J., Blumgart, L., Sperber, D., Hummer, A., and Fong, Y. (2003) Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer J. Clin. Oncol. 21, 3303-3309 10.1200/JCO.2003.03.142
28. Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Bally, M. B., and Janoff, A. S. (2006) Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice Mol. Cancer Ther. 5, 1854-1863 10.1158/1535-7163.MCT-06-0118
29. Chou, T.-C. (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method Cancer Res. 70, 440-446 10.1158/0008-5472.CAN-09-1947
30. Salvesen, G. S. and Dixit, V. M. (1997) Caspases: intracellular signaling by proteolysis Cell 91, 443-446 10.1016/S0092-8674(00)80430-4
31. Leist, M. and Jäättelä, M. (2001) Four deaths and a funeral: from caspases to alternative mechanisms Nat. Rev. Mol. Cell Biol. 2, 589-598 10.1038/35085008
32. Lakhani, S. A., Masud, A., Kuida, K., Porter, G. A., Booth, C. J., Mehal, W. Z., Inayat, I., and Flavell, R. A. (2006) Caspases 3 and 7: key mediators of mitochondrial events of apoptosis Science 311, 847-851 10.1126/science.1115035
33. Grütter, M. G. (2000) Caspases: key players in programmed cell death Curr. Opin. Struct. Biol. 10, 649-655 10.1016/S0959-440X(00)00146-9
34. Kawato, S., Kinosita, K., Jr, and Ikegami, A. (1978) Effect of cholesterol on the molecular motion in the hydrocarbon region of lecithin bilayers studied by nanosecond fluorescence techniques Biochemistry 17, 5026-5031 10.1021/bi00616a026